Glenmark Pharmaceuticals gets final approval for Diclofenac Sodium Gel, 3%
From USFDA
Glenmark Pharmaceuticals Inc. USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Diclofenac Sodium Gel, 3%, the generic version of Solaraze Gel, 3% of Fougera Pharmaceuticals Inc.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content